aminocamptothecin

DRUG4 trials

Sponsors

Yale University, NYU Langone Health, National Cancer Institute (NCI), University of Chicago

Conditions

Esophageal CancerGastric CancerLymphomaOvarian Cancer

Phase 2

Aminocamptothecin in Treating Patients With Stomach Cancer or Cancer of the Esophagus

CompletedNCT00003192

University of ChicagoEsophageal Cancer, Gastric Cancer

Start: 1998-03-31End: 2003-08-31Updated: 2013-09-05

Aminocamptothecin in Treating Patients With Refractory or Recurrent Hodgkin's Disease or Non-Hodgkin's Lymphoma

CompletedNCT00002745

National Cancer Institute (NCI)Lymphoma

Start: 1996-04-30End: 2008-01-31Updated: 2013-02-11

Aminocamptothecin in Treating Patients With Recurrent or Unresectable Epithelial Ovarian Cancer

CompletedNCT00002671

NYU Langone HealthOvarian Cancer

Start: 1995-12-31Updated: 2012-11-09

Aminocamptothecin in Treating Patients With T-cell Lymphoma

CompletedNCT00002635

Yale UniversityLymphoma

Start: 1995-05-31End: 2000-04-30Updated: 2013-07-26